{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:13Z","timestamp":1707524413445},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,16]]},"DOI":"10.7759\/cureus.21291","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T15:30:30Z","timestamp":1642347030000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin"],"prefix":"10.7759","author":[{"given":"Ruqaya","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtaza","family":"Dhrolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasim","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas MC","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016, 12:73-81. 10.1038\/nrneph.2015.173","journal-title":"Nat Rev Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-S011","article-title":"8. Pharmacologic approaches to glycemic treatment","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2017, 40:64-74. 10.2337\/dc17-S011","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00800209","article-title":"Frequency of hypoglycemia and its significance in chronic kidney disease","volume":"4","author":"Moen MF","year":"2009","unstructured":"Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4:1121-7. 10.2215\/CJN.00800209","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"3","author":"Salpeter S","year":"2003","unstructured":"Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2003, 3:CD002967. 10.1002\/14651858.CD002967","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations","volume":"20","author":"Lalau JD","year":"1999","unstructured":"Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf. 1999, 20:377-84. 10.2165\/00002018-199920040-00006","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.19","article-title":"Metformin and other antidiabetic agents in renal failure patients","volume":"87","author":"Lalau JD","year":"2015","unstructured":"Lalau JD, Arnouts P, Sharif A, De Broe ME. Metformin and other antidiabetic agents in renal failure patients. Kidney Int. 2015, 87:308-22. 10.1038\/ki.2014.19","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2534","article-title":"Should restrictions be relaxed for metformin use in chronic kidney disease? Yes, they should be relaxed! What's the fuss?","volume":"39","author":"Bakris GL","year":"2016","unstructured":"Bakris GL, Molitch ME. Should restrictions be relaxed for metformin use in chronic kidney disease? Yes, they should be relaxed! What's the fuss?. Diabetes Care. 2016, 39:1287-91. 10.2337\/dc15-2534","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi SE","year":"2014","unstructured":"Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014, 312:2668-75. 10.1001\/jama.2014.15298","journal-title":"JAMA"},{"key":"ref9","article-title":"Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients","volume":"32","author":"del Pozo-Fern\u00e1ndez C","year":"2012","unstructured":"del Pozo-Fern\u00e1ndez C, Pardo-Ruiz C, S\u00e1nchez-Botella C, et al.. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients. Nefrologia. 2012, 32:367-73.","journal-title":"Nefrologia"},{"key":"ref10","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin A","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, et al.. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3:1-150.","journal-title":"Kidney Int Suppl"},{"key":"ref11","unstructured":"Type 2 diabetes in adults. management | National Institute for Health and Care Excellence (NICE). (2017). Accessed: October 15, 2017: https:\/\/www.nice.org.uk\/guidance\/ng28."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12524","article-title":"American Diabetes Association Standards of Medical Care in Diabetes 2017","volume":"9","author":"Marathe PH","year":"2017","unstructured":"Marathe PH, Gao HX, Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes. 2017, 9:320-4. 10.1111\/1753-0407.12524","journal-title":"J Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.21.2594","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis","volume":"163","author":"Salpeter SR","year":"2003","unstructured":"Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003, 163:2594-602. 10.1001\/archinte.163.21.2594","journal-title":"Arch Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.220870","article-title":"Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients","volume":"28","author":"Bipi PK","year":"2017","unstructured":"Bipi PK, George J, Gomathy S, Gracious N, Kumar S, Mohandas MK. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients. Saudi J Kidney Dis Transpl. 2017, 28:1356-61. 10.4103\/1319-2442.220870","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy FF","year":"2014","unstructured":"Richy FF, Sabid\u00f3-Espin M, Guedes S, Corvino FA, Gottwald-Hostalek U. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care. 2014, 37:2291-5. 10.2337\/dc14-0464","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12515","article-title":"A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure","volume":"31","author":"Adam WR","year":"2014","unstructured":"Adam WR, O'Brien RC. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure. Diabet Med. 2014, 31:1032-8. 10.1111\/dme.12515","journal-title":"Diabet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin A","year":"2014","unstructured":"Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014, 85:49-61. 10.1038\/ki.2013.444","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc1208154","article-title":"Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion","volume":"369","author":"Kalantar-Zadeh K","year":"2013","unstructured":"Kalantar-Zadeh K, Uppot RN, Lewandrowski KB. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion. N Engl J Med. 2013, 369:374-82. 10.1056\/NEJMcpc1208154","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.5301\/jn.5000166","article-title":"Metformin in patients with chronic kidney disease: strengths and weaknesses","volume":"26","author":"Rocha A","year":"2013","unstructured":"Rocha A, Almeida M, Santos J, Carvalho A. Metformin in patients with chronic kidney disease: strengths and weaknesses. J Nephrol. 2013, 26:55-60.","journal-title":"J Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study","volume":"178","author":"Lazarus B","year":"2018","unstructured":"Lazarus B, Wu A, Shin JI, et al.. Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study. JAMA Intern Med. 2018, 178:903-10. 10.1001\/jamainternmed.2018.0292","journal-title":"JAMA Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196122","article-title":"Risk of lactic acidosis in type 2 diabetes patients using metformin: a case control study","volume":"13","author":"Aharaz A","year":"2018","unstructured":"Aharaz A, Potteg\u00e5rd A, Henriksen DP, Hallas J, Beck-Nielsen H, Lassen AT. Risk of lactic acidosis in type 2 diabetes patients using metformin: a case control study. PLoS One. 2018, 13:e0196122. 10.1371\/journal.pone.0196122","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.11.8923861","article-title":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus","volume":"81","author":"Cusi K","year":"1996","unstructured":"Cusi K, Consoli A, Defronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996, 81:4059-67. 10.1210\/jcem.81.11.8923861","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis","volume":"31","author":"Bodmer M","year":"2008","unstructured":"Bodmer M, Meier C, Kr\u00e4henb\u00fchl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008, 31:2086-91. 10.2337\/dc08-1171","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12017","article-title":"The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database","volume":"30","author":"Kajbaf F","year":"2013","unstructured":"Kajbaf F, Lalau JD. The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabet Med. 2013, 30:345-8. 10.1111\/dme.12017","journal-title":"Diabet Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013505428","article-title":"Unleash metformin: reconsideration of the contraindication in patients with renal impairment","volume":"47","author":"Lu WR","year":"2013","unstructured":"Lu WR, Defilippi J, Braun A. Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Ann Pharmacother. 2013, 47:1488-97. 10.1177\/1060028013505428","journal-title":"Ann Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Ekstr\u00f6m N","year":"2012","unstructured":"Ekstr\u00f6m N, Schi\u00f6ler L, Svensson AM, et al.. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012, 2:e001076. 10.1136\/bmjopen-2012-001076","journal-title":"BMJ Open"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1389-8","article-title":"Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases","volume":"20","author":"Pedr\u00f3s C","year":"2019","unstructured":"Pedr\u00f3s C, \u00c1vila M, G\u00f3mez-Lumbreras A, Manr\u00edquez M, Morros R. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases. BMC Nephrol. 2019, 20:193. 10.1186\/s12882-019-1389-8","journal-title":"BMC Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4","volume":"41","author":"Lalau JD","year":"2018","unstructured":"Lalau JD, Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Belpaire F, De Broe ME. Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4. Diabetes Care. 2018, 41:547-53. 10.2337\/dc17-2231","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0046-9","article-title":"Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function","volume":"52","author":"Duong JK","year":"2013","unstructured":"Duong JK, Kumar SS, Kirkpatrick CM, et al.. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet. 2013, 52:373-84. 10.1007\/s40262-013-0046-9","journal-title":"Clin Pharmacokinet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83307-a-comparative-study-of-acidosis-in-diabetic-advanced-chronic-kidney-disease-patients-on-and-off-metformin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:38Z","timestamp":1707507698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83307-a-comparative-study-of-acidosis-in-diabetic-advanced-chronic-kidney-disease-patients-on-and-off-metformin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.21291","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,16]]}}}